| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |